Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
What does it mean to be "healthy" when taking elexacaftor/tezacaftor/ivacaftor (ETI)? A qualitative study.
Everhart RS, McWilliams E, Maggs J, Sawicki GS, Sconiers T, Smith K, Yablon D, Butcher J, Prickett M, Bacon C, Goodman A, Gifford AH, Mayer-Hamblett N, Nichols DP, Riekert KA. Everhart RS, et al. Among authors: mcwilliams e. J Cyst Fibros. 2024 Nov 21:S1569-1993(24)01811-3. doi: 10.1016/j.jcf.2024.11.003. Online ahead of print. J Cyst Fibros. 2024. PMID: 39578180
Qualitative understanding of experiences of people with cystic fibrosis in a treatment discontinuation trial: The QUEST study.
Maggs J, Sawicki GS, Bacon C, McWilliams E, Yablon D, Ertman B, Sweeney L, Butcher JL, Everhart RS, Prickett M, Siracusa C, Gifford AH, Mayer-Hamblett N, Nichols DP, Goodman A, Woo T, Riekert KA. Maggs J, et al. Among authors: mcwilliams e. Contemp Clin Trials. 2025 Jan;148:107752. doi: 10.1016/j.cct.2024.107752. Epub 2024 Nov 17. Contemp Clin Trials. 2025. PMID: 39557157 Clinical Trial.
Cross-Cutting mHealth Behavior Change Techniques to Support Treatment Adherence and Self-Management of Complex Medical Conditions: Systematic Review.
Eaton CK, McWilliams E, Yablon D, Kesim I, Ge R, Mirus K, Sconiers T, Donkoh A, Lawrence M, George C, Morrison ML, Muther E, Oates GR, Sathe M, Sawicki GS, Snell C, Riekert K. Eaton CK, et al. Among authors: mcwilliams e. JMIR Mhealth Uhealth. 2024 May 1;12:e49024. doi: 10.2196/49024. JMIR Mhealth Uhealth. 2024. PMID: 38717433 Free PMC article. Review.
Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib.
McWilliams EM, Lucas CR, Chen T, Harrington BK, Wasmuth R, Campbell A, Rogers KA, Cheney CM, Mo X, Andritsos LA, Awan FT, Woyach J, Carson WE 3rd, Butchar J, Tridandapani S, Hertlein E, Castro CE, Muthusamy N, Byrd JC. McWilliams EM, et al. Blood Adv. 2019 Feb 12;3(3):447-460. doi: 10.1182/bloodadvances.2018025684. Blood Adv. 2019. PMID: 30737226 Free PMC article.
55 results